Company Analysis
Sign in

NuCana plc (NCNA)

Nasdaq: NCNA · Pharmaceutical Preparations · Edinburgh, GB · filing with the SEC since 2017
Full chart Alerts Compare
Grade5.0
◀ Past 4.3● Present 4.3▶ Future 6.1
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of pounds sterling (GBP), as filed; per-share figures in pounds sterling; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 19, 2026Mar 20, 2025Mar 20, 2024Apr 4, 2023Apr 27, 2022Mar 4, 2021Mar 10, 2020Mar 7, 2019Mar 22, 2018·
Research and development12,73718,01725,06236,42636,83425,89919,72816,84617,6737,904
General and administrative8,0964,9886,0637,2918,5297,0505,9535,1844,5731,143
Operating income-20,110-22,809-32,784-39,122-47,905-36,421-26,700-19,128-25,694-8,448
Finance costs12,64800·····1,794·
Finance income3863587546691032461,0491,065208283
Income before income taxes-30,521-22,451-32,030-38,453-47,802-36,175-25,651-18,063-25,486-8,165
Income tax expense-1,168-3,454-4,398-6,432-7,269-5,493-4,239-4,223-2,401-2,116
Income from continuing operations········-23,085-6,049
Net income-29,353-18,997-27,632-32,021-40,533-30,682-21,412-13,840-23,085-6,049
Earnings per share, basic0.00-0.26-0.53-0.61-0.78·····
Earnings per share, diluted0.00-0.26-0.53-0.61-0.78·····
Earnings per share, basic and diluted·····-0.81-0.66-0.43-0.89-0.25
Weighted average shares, basic11,231,52074,19152,57352,23552,04137,88232,32731,97226,06924,107
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:AdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton NCNA · research, not advice